From January to July 2023, Russian manufacturers produced 398.6 billion rubles’ worth of ready-made drugs (manufacturer’s prices, VAT included), down 0.3% from the same period in 2022. In physical terms, 2.26 billion packages were produced, down 6.9% from January–July 2022. If calculated in minimum dosage units (MDU), the production volume was 44.8 billion, down 2.3%.

Comprehensive ranking of logistics operators in the Russian pharmaceutical market in 2022.

Almost 80% of Russian doctors oppose the initiatives to increase the birth rate proposed by the Ministry of Health and the State Duma of the Russian Federation, according to a survey conducted by the RNC Pharma analyst company and the Medvestnik platform for doctors. In particular, 47.3% of the respondents consider these measures “perfunctory”, since only an increased welfare of the population and more social benefits can guarantee a decreased abortion rate.

In January–June 2023, Russian manufacturers produced 342.5 billion rubles’ worth of ready-made pharmaceutical drugs (manufacturer’s prices, VAT included), down 2.6% from the same period in 2022. In physical terms, the production volume was 1.97 billion packages, down 8.2%, or 39.0 billion minimum dosage units (MDU), down 3.8%.

In January–May 2023, Russian manufacturers produced 282 billion rubles’ of pharmaceutical drugs (manufacturer’s prices, VAT included), down 5.8% from the same period in 2022. In physical terms, the production volume was 1.64 billion packages, down 9.7% from January–May 2022. If calculated in minimum dosage units (MDU), Russian manufacturers produced 32.2 billion MDUs, down 3.9% from January–May 2022.